SDF-1-induced activation of ERK enhances HIV-1 expression

Eur Cytokine Netw. 2000 Sep;11(3):470-7.

Abstract

Chemokine receptors are not only able to bind chemokines but, together with CD4, they serve as an entry door for the human immunodeficiency virus type 1 (HIV-1). The signalling capacity of chemokine receptors, which is of fundamental importance for chemokine-induced chemotaxis, is not used by HIV-1 to enter a target cell, nor by chemokines or chemokine-derived ligands to inhibit viral entry. In addition, an ill-defined signal triggered by chemokines can, under some circumstances, lead to an increase in HIV-1 expression. We show here that, in infected cells, exposure to SDF-1 leads to an increased expression of a X4 strain of HIV-1. A similar increase can be induced by an N-terminal peptide of SDF-1 which had previously been shown to elicit an intracellular calcium response and to inhibit the entry of X4 strains of HIV-1. We demonstrate the involvement of extracellular signal-regulated kinases (ERK) in this phenomenon. SDF-1 activates ERK-1 and ERK-2 in Jurkat cells. In HeLa cells, ERK-2 only is activated by SDF-1 or by a SDF-derived peptide. This ERK activation can be blocked by pertussis toxin and by the MEK inhibitor U0126. Most importantly, SDF-1-dependent HIV-1 expression is abolished by pretreating the cells with pertussis toxin or with U0126. The consequences of this SDF-1-induced, ERK-dependent modulation of HIV-1 expression in infected cells may have a clinical relevance for eradicating latent viruses.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / pharmacology*
  • Butadienes / pharmacology
  • CD4 Antigens / genetics
  • CD4 Antigens / physiology
  • Calcium / metabolism
  • Cell Cycle
  • Chemokine CXCL12
  • Chemokines, CXC / pharmacology*
  • Enzyme Activation
  • Enzyme Inhibitors / pharmacology
  • HIV Long Terminal Repeat / genetics
  • HIV-1 / drug effects
  • HIV-1 / genetics
  • HIV-1 / physiology*
  • HeLa Cells
  • Humans
  • Jurkat Cells
  • Mitogen-Activated Protein Kinases / metabolism*
  • Nitriles / pharmacology
  • Peptide Fragments / pharmacology
  • Receptors, CXCR4 / physiology
  • Transcription, Genetic
  • Transfection
  • Virus Replication / drug effects*

Substances

  • Anti-HIV Agents
  • Butadienes
  • CD4 Antigens
  • CXCL12 protein, human
  • Chemokine CXCL12
  • Chemokines, CXC
  • Enzyme Inhibitors
  • Nitriles
  • Peptide Fragments
  • Receptors, CXCR4
  • U 0126
  • Mitogen-Activated Protein Kinases
  • Calcium